The influence of treatment on hormone receptor subgroups and breast cancer-specific mortality within US integrated healthcare systems
ConclusionOur findings suggest that ER + /PR− tumors may have worse breast cancer-specific mortality than ER + /PR + tumors in a community setting.
Source: Cancer Causes and Control - Category: Cancer & Oncology Source Type: research
More News: Breast Cancer | Cancer | Cancer & Oncology | Chemotherapy | Clinical Trials | Endocrine Therapy | Hormones | Women